Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Christian Gessner, Frederik Trinkmann, Sanaz Bahari Javan, Raimund Hövelmann, Valentina Bogoevska, George Georges, Elena Nudo & Carl-Peter Criée. (2022) Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 3019-3031.
Read now
Read now
Rezwanul Hasan Rana, Khorshed Alam, Syed Afroz Keramat & Jeff Gow. (2022) Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review. Expert Review of Respiratory Medicine 16:10, pages 1067-1084.
Read now
Read now
Leah B Sansbury, Chanchal Bains, David A Lipson, Afisi S Ismaila & Sarah H Landis. (2021) Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1255-1264.
Read now
Read now
Antoni Sicras-Mainar, Francisco J de Abajo & José Luis Izquierdo-Alonso. (2020) Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3291-3302.
Read now
Read now
Omar S Usmani, Nicola Scichilone, Benjamin Mignot, Dennis Belmans, Cedric Van Holsbeke, Jan De Backer, Roberta De Maria, Erika Cuoghi, Eva Topole & George Georges. (2020) Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2433-2440.
Read now
Read now
José Luis López-Campos, Bernardino Alcázar Navarrete, Juan Antonio Riesco Miranda, Borja G Cosío, Juan P de-Torres, Bartolomé Celli, Carlos A Jiménez-Ruiz & Ciro Casanova Macario. (2020) A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1801-1811.
Read now
Read now
Hannah B Lewis, Melanie Schroeder, Necdet B Gunsoy, Ellen M Janssen, Samuel Llewellyn, Helen A Doll, Paul W Jones & Afisi S Ismaila. (2020) Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 595-604.
Read now
Read now
Chih-Cheng Lai, Cheng-Hsin Chen, Charlotte Yu Hsuan Lin, Cheng-Yi Wang & Ya-Hui Wang. (2019) The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1539-1548.
Read now
Read now
Maciej Kupczyk & Piotr Kuna. (2019) Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 13:1, pages 5-11.
Read now
Read now
Dave Singh. (2018) Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 19:11, pages 1279-1287.
Read now
Read now
Edward M Kerwin, Robert Tosiello, Barry Price, Shahin Sanjar & Thomas Goodin. (2018) Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2917-2929.
Read now
Read now
Marco Mantero, Dejan Radovanovic, Pierachille Santus & Francesco Blasi. (2018) Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2319-2333.
Read now
Read now
Articles from other publishers (17)
Emanuela Resta, Giulia Scioscia, Donato Lacedonia, Carla Maria Irene Quarato, Francesco Panza, Onofrio Resta, Giorgia Lepore, Enrico Buonamico, Valentina Di Lecce, Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro & Noemi Rossi. (2022) Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region. BMC Health Services Research 22:1.
Crossref
Crossref
Liansheng Zhang, Xiaoqing Wang, Ye Zhang & Wenyu Chen. (2022) Efficacy and Safety of Single Inhaler Triple Therapy Versus Separate Triple Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Clinical Therapeutics 44:6, pages 859-873.
Crossref
Crossref
Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri & Nicola Scichilone. (2022) Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution. Therapeutic Advances in Respiratory Disease 16, pages 175346662110660.
Crossref
Crossref
Omar S. Usmani, Rajiv Dhand, Federico Lavorini & David Price. (2021) Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease. Mayo Clinic Proceedings 96:9, pages 2448-2463.
Crossref
Crossref
S. N. Avdeev & N. V. Trushenko. (2021) New triple combination of beclomethasone dipropionate, glycopyrronium bromide and formoterol fumarate in the treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA 31:3, pages 365-373.
Crossref
Crossref
Hyun Woo Lee, Hyung Jun Kim, Eun Jin Jang & Chang-Hoon Lee. (2021) Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis. Respiration 100:7, pages 631-643.
Crossref
Crossref
James Dean, Catalina Panainte, Naimat Khan & Dave Singh. (2020) The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD. Respiratory Research 21:1.
Crossref
Crossref
Alberto Zucchelli, Davide L. Vetrano, Elisa Bianchini, Francesco Paolo Lombardo, Alessio Piraino, Marco Zibellini, Alberto Ricci, Alessandra Marengoni, Francesco Lapi & Claudio Cricelli. (2020) Adherence to COPD free triple inhaled therapy in the real world: a primary care based study. The Clinical Respiratory Journal 14:8, pages 732-739.
Crossref
Crossref
Sundeep Salvi, Ashish Kumar Deb, Mayank Agarwal, Venkateswara Reddy Tummuru, Rahul Kodgule, V.S. Hemalatha, Anil Kumar Awasthi, K.P. Suraj, Vinod Kumar Pavitran, Shashi Prakash Mourya, Paul Thomas, Abhijit Vaidya, Sushmeeta Chhowala & Jaideep Gogtay. (2020) Fixed-dose combination of three drugs, i.e. LABA/LAMA/ICS for COPD: Results of a real-world study from India. Pulmonary Pharmacology & Therapeutics 63, pages 101932.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal & Bernardino Alcázar Navarrete. (2020) Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente. Archivos de Bronconeumología 56:4, pages 242-248.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal & Bernardino Alcázar Navarrete. (2020) The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient. Archivos de Bronconeumología (English Edition) 56:4, pages 242-248.
Crossref
Crossref
Sergey N. Avdeev & Natal’ya V. Trushenko. (2019) Triple therapy in chronic obstructive pulmonary disease. Russian Pulmonology 29:2, pages 199-206.
Crossref
Crossref
Luigino Calzetta, Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2019) Adding a LAMA to ICS/LABA Therapy. Chest 155:4, pages 758-770.
Crossref
Crossref
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid & Leonardo M. Fabbri. (2019) Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box. ERJ Open Research 5:1, pages 00185-2018.
Crossref
Crossref
Jose Luis Lopez-Campos, Laura Carrasco-Hernandez, Esther Quintana-Gallego, Carmen Calero-Acuña, Eduardo Márquez-Martín, Francisco Ortega-Ruiz & Joan B. Soriano. (2019) Triple therapy for COPD: a crude analysis from a systematic review of the evidence. Therapeutic Advances in Respiratory Disease 13, pages 175346661988552.
Crossref
Crossref
Hana Kotolová & Tomáš Hammer. (2018) Chronic obstructive pulmonary disease. Praktické lékárenství 14:4, pages 156-160.
Crossref
Crossref
Mario Cazzola, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2018)
Triple therapy
versus
single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
. European Respiratory Journal 52:6, pages 1801586.
Crossref
Crossref